CRP and COVID-19: For example, Astapovskii et al. (2022) demonstrated that MR-proADM exhibited higher prognostic value than routine inflammatory markers—including leukocyte and neutrophil counts, C-reactive protein (CRP), procalcitonin (PCT)—as well as the National Early Warning Score (NEWS), for predicting outcomes in COVID-19 patients [41].